罗氏公司宣布，已在全球范围内部署超过3500颗英伟达Blackwell架构GPU。这一大规模技术投入旨在显著提升药物研发效率、推动新一代诊断技术发展，并优化生产制造流程。
通过整合英伟达尖端计算能力，罗氏将加速医疗领域的创新突破。Blackwell GPU的高性能运算将直接赋能其研发管线，助力更精准的疾病诊断方案开发，同时实现生产环节的智能化升级。
此次合作标志着医疗科技与人工智能计算的深度融合。英伟达的加速计算平台正成为推动生物制药行业数字化转型的关键基础设施，为全球医疗健康产业带来新的发展动能。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.